Furthermore, BNC101, a mAb with high affinity for Lgr5, exhibited antitumor activity that led to prolonged survival in multiple mouse models with CRC patient-derived xenograft (PDX) tumors [193, 194]. This evidence concerns the gene LGR5 and colorectal carcinoma.